Annual Long Term Debt
$6.09 M
+$6.09 M+100.00%
31 December 2023
Summary:
Cara Therapeutics annual long term debt is currently $6.09 million, with the most recent change of +$6.09 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$2.42 million (+65.75%). CARA annual long term debt is now at all-time high.CARA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$0.00
-$7.32 M-100.00%
30 September 2024
Summary:
Cara Therapeutics quarterly long term debt is currently $0.00, with the most recent change of -$7.32 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$6.82 million (-100.00%). CARA quarterly long term debt is now -100.00% below its all-time high of $7.32 million, reached on 30 June 2024.CARA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CARA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | +65.8% | -100.0% |
| 5 y5 years | +100.0% | -100.0% |
CARA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | ||
| 5 y | 5 years | at high | -100.0% | ||
| alltime | all time | at high | -100.0% |
Cara Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) |
| June 2024 | - | $7.32 M(+7.3%) |
| Mar 2024 | - | $6.83 M(+12.1%) |
| Dec 2023 | $6.09 M(>+9900.0%) | $6.09 M(-10.7%) |
| Sept 2023 | - | $6.82 M(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $497.00 K(-49.4%) |
| June 2022 | - | $983.00 K(-32.4%) |
| Mar 2022 | - | $1.46 M(-24.1%) |
| Dec 2021 | $1.92 M | $1.92 M(-19.2%) |
| Sept 2021 | - | $2.37 M(-15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.82 M(-13.3%) |
| Mar 2021 | - | $3.25 M(-11.5%) |
| Dec 2020 | $3.67 M(+9.6%) | $3.67 M(+36.5%) |
| Sept 2020 | - | $2.69 M(-9.1%) |
| June 2020 | - | $2.96 M(-4.4%) |
| Mar 2020 | - | $3.10 M(-7.6%) |
| Dec 2019 | $3.35 M(>+9900.0%) | $3.35 M(-6.9%) |
| Sept 2019 | - | $3.60 M(-6.4%) |
| June 2019 | - | $3.85 M(-5.8%) |
| Mar 2019 | - | $4.09 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cara Therapeutics annual long term debt?
- What is the all time high annual long term debt for Cara Therapeutics?
- What is Cara Therapeutics annual long term debt year-on-year change?
- What is Cara Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Cara Therapeutics?
- What is Cara Therapeutics quarterly long term debt year-on-year change?
What is Cara Therapeutics annual long term debt?
The current annual long term debt of CARA is $6.09 M
What is the all time high annual long term debt for Cara Therapeutics?
Cara Therapeutics all-time high annual long term debt is $6.09 M
What is Cara Therapeutics annual long term debt year-on-year change?
Over the past year, CARA annual long term debt has changed by +$6.09 M (+100.00%)
What is Cara Therapeutics quarterly long term debt?
The current quarterly long term debt of CARA is $0.00
What is the all time high quarterly long term debt for Cara Therapeutics?
Cara Therapeutics all-time high quarterly long term debt is $7.32 M
What is Cara Therapeutics quarterly long term debt year-on-year change?
Over the past year, CARA quarterly long term debt has changed by -$6.82 M (-100.00%)